Next Bt Co. Ltd (065170) - Total Liabilities
Based on the latest financial reports, Next Bt Co. Ltd (065170) has total liabilities worth ₩11.11 Billion KRW (≈ $7.53 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Next Bt Co. Ltd cash conversion from operations to assess how effectively this company generates cash.
Next Bt Co. Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Next Bt Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 065170 financial resilience to evaluate the company's liquid asset resilience ratio.
Next Bt Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Next Bt Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bonia Corporation Bhd
KLSE:9288
|
Malaysia | RM254.88 Million |
|
Barratt Redrow plc
LSE:BTRW
|
UK | GBX3.50 Billion |
|
Alpha Exploration Ltd
V:ALEX
|
Canada | CA$395.82K |
|
Korea Circuit Co Ltd
KO:007815
|
Korea | ₩568.49 Billion |
|
Lii Hen Industries Bhd
KLSE:7089
|
Malaysia | RM104.70 Million |
|
Bintang Samudera Mandiri Lines Tbk PT
JK:BSML
|
Indonesia | Rp96.90 Billion |
|
Dongyang Piston Co Ltd
KO:092780
|
Korea | ₩283.87 Billion |
|
HCL Infosystems Limited
NSE:HCL-INSYS
|
India | Rs7.25 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Next Bt Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Next Bt Co. Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Next Bt Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Next Bt Co. Ltd (2008–2024)
The table below shows the annual total liabilities of Next Bt Co. Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩12.21 Billion ≈ $8.28 Million |
-6.08% |
| 2023-12-31 | ₩13.00 Billion ≈ $8.81 Million |
-81.39% |
| 2022-12-31 | ₩69.89 Billion ≈ $47.36 Million |
-2.73% |
| 2021-12-31 | ₩71.84 Billion ≈ $48.69 Million |
+5.31% |
| 2020-12-31 | ₩68.22 Billion ≈ $46.23 Million |
+56.26% |
| 2019-12-31 | ₩43.66 Billion ≈ $29.59 Million |
-0.69% |
| 2018-12-31 | ₩43.97 Billion ≈ $29.80 Million |
-8.51% |
| 2017-12-31 | ₩48.06 Billion ≈ $32.57 Million |
-2.59% |
| 2016-12-31 | ₩49.34 Billion ≈ $33.43 Million |
+39.63% |
| 2015-12-31 | ₩35.33 Billion ≈ $23.95 Million |
+21.16% |
| 2014-12-31 | ₩29.16 Billion ≈ $19.76 Million |
-15.61% |
| 2013-12-31 | ₩34.56 Billion ≈ $23.42 Million |
-3.19% |
| 2012-12-31 | ₩35.70 Billion ≈ $24.19 Million |
-6.91% |
| 2011-12-31 | ₩38.35 Billion ≈ $25.99 Million |
+2.50% |
| 2010-12-31 | ₩37.41 Billion ≈ $25.35 Million |
-1.04% |
| 2009-12-31 | ₩37.81 Billion ≈ $25.62 Million |
-35.88% |
| 2008-12-31 | ₩58.96 Billion ≈ $39.96 Million |
-- |
About Next Bt Co. Ltd
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin, South Korea.